Douglas Krulik has filed a Form 4 with the SEC, detailing several stock transactions related to his role at PetMed Express, Inc. This filing is significant as it reflects ongoing changes in ownership and management dynamics within the company.

Background

PetMed Express, Inc. operates in the retail drug stores and proprietary stores sector. The company is based in Delray Beach, Florida, and its central index key is 0001040130. The recent filings indicate that Krulik is the Chief Administrative Officer (CAO) and Interim Chief Financial Officer (CFO) of the company.

What the Filing Says

The filing, dated November 6, 2026, includes several stock transactions by Krulik. Notably, it states: "This Form 4 is being filed to report the surrender by the Reporting Person to the Issuer of shares in satisfaction of tax withholding obligations applicable to the vesting of restricted stock units and restricted stock awards." This indicates that Krulik has surrendered shares to cover tax obligations related to his stock awards.

Impact

These transactions may affect the overall ownership structure of PetMed Express, as Krulik's actions could influence investor perception and company governance. The retail drug store sector may also feel the ripple effects as competitors observe these changes in management and ownership strategies.

What's Next

The filing does not say what happens next.